The tumor cells secrete interleukin-33 cytokine, which causes myeloid cell differentiation into macrophage and consequently stimulates TGF-β signals to reach cancer stem cells, resulting in the progression of malignant tumors and drug resistance (153). This evidence concerns the gene IL33 and cancer.